市場調查報告書
商品編碼
1374217
神經監測設備全球市場規模、佔有率和行業趨勢分析報告:2023-2030 年按技術、產品和地區分類的展望和預測Global Nerve Monitoring Devices Market Size, Share & Industry Trends Analysis Report By Technology, By Product (Monitors, Electrodes, and Ancillary Products), By Regional Outlook and Forecast, 2023 - 2030 |
神經監測設備市場規模預計到 2030 年將達到 18 億美元,預測期內年複合成長率年成長率為 5.2%。
根據 KBV Cardinal 矩陣中發布的分析,美敦力公司 (Medtronic PLC) 是市場領導者。 工業、Brainlab AG 和 Natus Medical Inc. 等公司是市場上的主要創新者。 2023 年 1 月,Natus Medical Incorporated 完成了對神經生理學領域全球領導者 Micromed Holding SAS 的收購。透過此次收購,神經科學用戶現在可以透過整合資源獲得全面的產品、全球服務和支援。
市場成長要素
由於外科手術的增加導致產品需求增加
許多外科手術都有固有的風險,包括神經損傷的可能性。神經監測設備可幫助外科醫生和醫療保健專業人員即時識別和監測神經功能,降低手術期間無意損傷神經的風險。這種風險降低對於複雜且敏感的神經外科手術尤其重要。外科技術的進步擴大了外科手術的範圍,包括微創手術和機器人輔助手術。這些先進的手術通常需要精確的神經系統監測,以確保最佳的結果和安全。耳鼻喉科手術的增加增加了對神經監測設備的需求。隨著手術技術的發展和手術需求的增加,提高病人安全和手術效果的需求變得迫切,預計市場將繼續發展。
神經監測設備的技術進步
技術進步正在顯著推動市場成長。這些進步促進了更複雜、更準確、更易於使用的神經監測設備的發展,這些設備在各種手術和醫療情況中變得越來越有價值。現代神經監測設備為外科醫生和醫療團隊提供即時監測和即時回饋。這些即時資訊可以在手術過程中及時進行調整,並降低神經損傷的風險。神經監測設備擴大與手術導航系統整合,從而可以精確繪製和追蹤神經途徑。外科醫生可以使用這些系統更準確地規劃和執行手術。先進的軟體功能改進了資料分析和視覺化。這些技術進步正在擴大可以進行研究監測的手術範圍,並提高神經監測設備在醫療機構中的整體普及。
市場抑制因素
需要大量前期投資
神經監測設備屬於資本集中設備,需要醫療機構進行大量的前期投資。這項費用可能會使醫院的資源緊張,尤其是預算有限的小型或非營利組織。除了最初的購買成本之外,還存在維護和操作神經監測設備的持續成本。這包括定期維護、校準以及購買拋棄式電極和配件的成本。高成本可能導致全球在獲得先進醫療技術方面存在差異。在某些地區,由於成本相關要素,神經監測設備的使用可能受到限制。這些要素阻礙了市場的成長。
產品展望
依產品分類,市場分為監視器、電極和輔助產品。 2022年,顯示器部門市場以最大的收益佔有率主導市場。這是由於外科手術、神經系統疾病的增加和技術的進步。主監測單元或裝置接收來自電極的訊號並處理資料。通常顯示有關神經功能的即時資訊。該設備還可以包括用於資料分析和視覺化的軟體。這使得醫療保健專業人員能夠在手術和醫療過程中追蹤神經活動。預計未來年度對拋棄式海綿盤、拋棄式過濾器、酒精棉籤、拋光凝膠和電極洗液的需求將會增加。利用率的提高和重複購買預計將推動該領域的成長。
技術展望
根據技術,市場分為腦電圖(EEG)、誘發電位、肌電圖(EMG)和皮質電圖(ECoG)。 2022 年,肌電圖 (EMG) 領域在神經監測設備市場中佔據了顯著的收益佔有率。肌電圖是醫療保健專業人員診斷和監測影響神經肌肉系統狀況的寶貴工具。肌電圖測試的結果可以指南治療決策、復健計畫和神經肌肉疾病的管理。肌電圖測試通常具有良好的耐受性,插入電極針期間的任何不適或輕微疼痛通常都是暫時的。肌電圖測試通常由神經科、臨床神經生理學家或經過專門培訓的實驗室技術人員進行。
區域展望
從區域來看,我們對北美、歐洲、亞太地區和拉丁美洲地區的市場進行了分析。 2022年,北美地區將佔據市場最大的收益佔有率。原因是複雜的醫療保健系統以及在創傷病例中擴大使用神經監測。此外,可支配所得的增加和有利的報銷政策有利於預防和早期診斷,增加了對神經監測設備的需求。心血管疾病是美國的首要死因。由於心臟疾病的高患病,進行了大量的心臟外科手術,這可能導致神經損傷。
The Global Nerve Monitoring Devices Market size is expected to reach $1.8 billion by 2030, rising at a market growth of 5.2% CAGR during the forecast period.
Somatosensory Evoked Potentials (SSEPs) are a type of neurophysiological test used in clinical medicine to assess the function of the somatosensory pathways in the nervous system. SSEP testing involves measuring the electrical signals generated in response to sensory stimuli applied to specific peripheral nerves. Therefore, Somatosensory Evoked Potentials (SSEPs) segment generated $63.4 million revenue in the market in 2022. These tests provide valuable information about the integrity and function of sensory pathways, helping diagnose and monitor various neurological conditions. SSEP testing involves two primary steps: stimulation and recording. During stimulation, a controlled electrical stimulus or mechanical vibration is applied to a specific peripheral nerve, typically at various points along the limb. The stimulus travels along the sensory pathway towards the central nervous system.
The major strategies followed by the market participants are Mergers & Acquisition as the key developmental strategy to keep pace with the changing demands of end users. For instance, In September, 2022, Brainlab AG took over Dr. Langer Medical GmbH. Through this acquisition, Brainlab integrated Dr. Langer Medical GmbH's neuromonitoring services and solutions to amplify neuronavigation through the integration of critical data components. Additionally, In October, 2020, Medtronic PLC announced the acquisition of Avenu Medical, Inc. Through this acquisition, Medtronic has supported the vascular access care continuum and provided endovascular therapies to patients suffering from ESRD across the world.
Based on the Analysis presented in the KBV Cardinal matrix; Medtronic PLC is the forerunner in the Market. Companies such as Nihon Kohden Corporation, Brainlab AG, Natus Medical Inc. are some of the key innovators in the Market. In January, 2023, Natus Medical Incorporated completed the acquisition of Micromed Holding SAS, a global leader in neurophysiology. Through this acquisition, neuroscience users are able to access comprehensive products, global service and support through the combined resources.
Market Growth Factors
Rising demand for product owing to increasing surgical procedures
Many surgical procedures carry inherent risks, including the potential for nerve damage. Nerve monitoring devices help surgeons and healthcare professionals identify and monitor nerve function in real-time, reducing the risk of unintentional nerve injury during surgery. This risk mitigation is especially crucial in complex and delicate nervous system surgeries. Advances in surgical techniques have expanded the scope of surgical procedures, including minimally intrusive and robotic-assisted surgeries. These advanced procedures often require precise nerve monitoring to ensure optimal outcomes and safety. The increasing number of ENT surgeries contributes to the demand for nerve monitoring devices. As surgical techniques evolve and the demand for surgical procedures grows, the market is expected to develop continually, driven by the imperative to enhance patient safety and surgical outcomes.
Technological advancements in nerve monitoring devices
Technological advancements have significantly driven growth in the market. These advancements have led to the development of more sophisticated, accurate, and user-friendly nerve monitoring devices, making them increasingly valuable in various surgical and medical contexts. Modern nerve monitoring devices offer surgeons and medical teams real-time monitoring and immediate feedback. This real-time information allows for timely adjustments during surgery, reducing the risk of nerve damage. Nerve monitoring devices are increasingly integrated with surgical navigation systems, allowing for precise mapping, and tracking of nerve pathways. Surgeons can use these systems to plan and execute procedures more accurately. Advanced software capabilities have improved data analysis and visualization. These technological advancements have extended the range of surgeries where nerve monitoring is feasible and increased the overall adoption of nerve monitoring devices in healthcare settings.
Market Restraining Factors
Requirement of substantial upfront investments
Nerve monitoring devices can be capital-intensive, requiring a substantial upfront investment by healthcare facilities. This expenditure may strain the financial resources of hospitals, particularly smaller or non-profit institutions with limited budgets. Beyond the initial purchase cost, ongoing expenses are associated with maintaining and operating nerve monitoring devices. This includes the cost of regular maintenance, calibration, and the purchase of disposable electrodes and accessories. High costs can contribute to global disparities in access to advanced healthcare technologies. Some regions may have limited access to nerve monitoring devices due to cost-related factors. Due to such factors, market growth will be hampered.
Product Outlook
On the basis of product, the market is segmented into monitors, electrodes, and ancillary products. In 2022, the monitors segment dominated the market with the maximum revenue share. Due to the increasing number of surgical processes, neurological disorders, and technological advancements. The main monitoring unit or device receives signals from the electrodes and processes the data. It typically displays real-time information about nerve function. This equipment may have built-in software for data analysis and visualization. It allows healthcare professionals to track nerve activity during surgery or medical procedures. In the coming years, disposable sponge disks, disposable filters, alcohol swabs, abrasive gel, and electrode lotions are expected to increase in demand. Increased utilization and repeat purchases will likely drive segment growth.
Technology Outlook
Based on technology, the market is fragmented into electroencephalogram (EEG), evoked potential, electromyography (EMG), and electrocorticography (ECoG). The electromyography (EMG) segment recorded a remarkable revenue share in the nerve monitoring device market in 2022. EMG is a valuable tool for healthcare professionals to diagnose and monitor conditions affecting the neuromuscular system. The results of EMG testing help guide treatment decisions, rehabilitation programs, and the management of neuromuscular disorders. The procedure is generally well-tolerated, and discomfort or mild pain during needle electrode insertion is usually temporary. EMG testing is typically performed by neurologists, clinical neurophysiologists, or specially trained technologists.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region witnessed the largest revenue share in the market. Due to its sophisticated healthcare system and the rising usage of nerve monitoring in trauma cases. Moreover, rising disposable income and favorable reimbursement policies facilitate preventive & early diagnosis, thereby increasing the demand for nerve monitoring devices. Cardiovascular disease is the foremost cause of death in the US. As a result of the high prevalence of cardiac disease, numerous cardiological surgical procedures are conducted, which can potentially lead to nerve damage.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, NuVasive, Inc., Natus Medical Inc., Neuspera Medical, Inc., Brainlab AG, Checkpoint Surgical, Inc., Cadwell Industries, Inc., Compumedics Limited, Magstim EGI (Magstim, Inc.), and Nihon Kohden Corporation.
Recent Strategies Deployed in Nerve Monitoring Devices Market
Partnerships, Collaborations, and Agreements:
Aug-2023: Brainlab AG expanded its partnership with ZimVie Inc., a global life sciences leader in the dental and spine markets. Through this extended partnership, ZimVie's Vital and Virage spinal fixation systems were amalgamated with the spine and trauma technologies of Brainlab. Additionally, the companies helped surgeons to place pedicle screws, minimize exposure of radiation and plan and execute spinal procedures.
Product Launches and Product Expansions:
Aug-2023: Cadwell Industries, Inc. released the Sierra NMUS1 neuromuscular ultrasound device which helps in providing electrodiagnostic medicine. The Sierra NMUS1 provides high-resolution neuromuscular and musculoskeletal ultrasound, needle guidance capabilities along with combined controls and an organized interface in the Sierra 4 software.
Apr-2023: Cadwell Industries, Inc. unveiled the Arc Voyager which is a solution for remotely monitoring wireless In-Home EEG. The Arc Voyager along with the Arc Apollo+ EEG can be used by the physicians for regulating the data of the patients using in-home ambulatory tests.
Oct-2022: Nihon Kohden Corporation introduced the Smart Cable NMT Pod and disposable electrode which assists clinicians in the regulation of neuromuscular blockade. The Smart Cable NMT Pod and disposable electrode monitors the depth of paralysis of the patient during surgery after the administration of the neuromuscular blockade agent (NMBA).
Sep-2022: Checkpoint Surgical, Inc. added the CHECKPOINT GEMINI to its intraoperative nerve stimulators. Checkpoint Gemini has the features of a bipolar probe design thus helping to focus the released energy into a limited area. Additionally, the Checkpoint Gemini provides precise stimulation and helps the surgeons with optimal solutions relating to clinical nerve procedures.
Jul-2022: Checkpoint Surgical, Inc. introduced the Checkpoint Edge Nerve Cutting Kit into its portfolio of intraoperative nerve care. The Checkpoint Edge added new features into the company's stimulator and implant products. Additionally, the Checkpoint Edge assisted the surgeon in protecting and preserving nerve tissue at the time of nerve transection.
Acquisition and Mergers:
Jan-2023: Natus Medical Incorporated completed the acquisition of Micromed Holding SAS, a global leader in neurophysiology. Through this acquisition, the neuroscience users able to access comprehensive products, global service and support through the combined resources.
Sep-2022: Brainlab AG took over Dr. Langer Medical GmbH, a manufacturer of medical equipment and medical devices. Through this acquisition, Brainlab integrated Dr. Langer Medical GmbH's neuromonitoring services and solutions to amplify neuronavigation through the integration of critical data components.
May-2022: Brainlab AG completed the acquisition of medPhoton GmbH, engaged in manufacturing robotic imaging solutions. Through this acquisition, Loop-X was upgraded and the roadmap for intraoperative imaging was paved.
Feb-2021: NuVasive, Inc. acquired Simplify Medical Inc., engaged in designing and manufacturing cervical artificial discs. Through this acquisition, the clinically effective cTDR technology was added to NuVasive's portfolio. Additionally, the acquisition upgraded NuVasive's growth strategy of expansion of its portfolio through industry-leading innovation.
Oct-2020: Medtronic PLC announced the acquisition of Avenu Medical, Inc., a medical device company. Through this acquisition, Medtronic has supported the vascular access care continuum and provided endovascular therapies to patients suffering from ESRD across the world.
Feb-2020: Medtronic PLC took over Digital Surgery, a privately held pioneer in surgical artificial intelligence (AI), data and analytics. Through this acquisition, Medtronic upgraded its portfolio and the robotic-assisted surgery platform. Additionally, the acquisition helped combining robotic platforms and instrumentations digitally thus expanding the reach of patients.
Market Segments covered in the Report:
By Technology
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research